Chengdu King-Tiger Pharm-Chem. Tech. Co., Ltd. logo

Chengdu King-Tiger Pharm-Chem. Tech. Co., Ltd.

Request information


Chengdu King-tiger Pharm-chem. Tech. Co., Ltd., founded in the year of 2007, is the few professional manufacturer for the series of natural high purity products, such as Astragalus extract (Astragaloside IV and Cycloastragenol), Gardenia jasminoides Ellis extract (Genipin, Geniposide and Geniposidic acid) in China.

Our core business is researching and developing, separating and purifying from the traditional Chinese medicine and natural plant herb to find compounds which have significant biological activity; Our main products include Astragaloside IV, Cycloastragenol, Genipin etc.

Our extraction and refined production factory, which is running under the GMP requirement, is located in Southwest HangKong Harbor Pharmaceutical Developing District. In 2009, we established the new R & D center in Tianfu Life Science Park, Chengdu city.

The R & D center with highly qualified R & D team, equipped with HPLC, UV and other advanced equipment and testing instruments, focused on researching new products and new technology etc.

The extraction and refined production factory is mainly used to produce our high purity natural plant extract to meet the domestic and international markets.

Its processing capacity is up to 1,000 tons per year. This factory has complete sets of equipment, such as pre-processing, concentration, extraction, column chromatography separation, refrigeration, spray drying and vacuum drying etc.

All products are produced under GMP condition and strictly tested by MS, NMR, and HPLC. Now we regularly produced Astragalsoide IV 0.3% to 98%, Cycloastragenol 1% to 98%, and high purity Genipin.

Business type
Main category
Health Care
Main products
Astragaloside IV, Cycloastragenol, Calycosin-7-O-beta-D-glucoside
Year established
Export markets

Contact info

B6 - 502, Tianfu Life Science Park, No. 88 South Keyuan Road, Gaoxin District, Chengdu City, Sichuan Province, PRC. 610041
On Bikudo since 2023
Editor verified